TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination, utilizing its premier Binary Ionization Technology (BIT) platform through its SteraMist products – a hydrogen peroxide-based mist and fog composed of ionized Hydrogen Peroxide (iHP), announced that it has received a purchase order from a multinational top five pharmaceutical company. The order is comprised of TOMI’s SteraMist Environment system and validation service, for use at several of the Company’s locations. Based on its ongoing conversations with this customer, TOMI understands that this is an initial order for a new facility, and the Company expects additional future follow-on orders for this partner’s multiple locations for both additional environment systems and our Custom Engineered System (CES) across the U.S. and Europe.
Elissa J. (E.J.) Shane, TOMI’s COO, states, “As we continue to partner with large, global pharmaceutical companies and with the many advantages of SteraMist iHP technology has to offer, our partners are expanding SteraMist decontamination throughout their numerous facilities. As we prove the value of our technology and products, we are well positioned for follow-on business. We are excited to expand this opportunity to permanently integrate SteraMist iHP technology with the installation and implementation of the CES product line, both domestically and internationally with this prestigious customer, promoting our SteraMist brand on a global level and demonstrating our commitment to disinfection around the world with our premier client base. Life science partners take time to establish, and the industry experienced a pause due to COVID-19, but these strong partnerships have proven profitable, and we continue to strive to represent the industry standard.”
SteraMist ionized Hydrogen Peroxide (iHP) technology produces a non-hazardous, eco-friendly disinfection while leaving no byproducts behind which aligns with the company’s focus on corporate responsibility and sustainability initiatives. TOMI partnership with this leading pharmaceutical company complements its work with other established Life Science pharmaceutical customers such as Pfizer and Catalent.
Related Posts
